Drug Shortage Report for NEURONTIN

Last updated on 2018-01-30 History
Report ID 34010
Drug Identification Number 02084279
Brand name NEURONTIN CAP 300MG
Common or Proper name NEURONTIN
Company Name BGP PHARMA ULC
Market Status MARKETED
Active Ingredient(s) GABAPENTIN
Strength(s) 300MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 100's
ATC code N03AX
ATC description ANTIEPILEPTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-01-02
Estimated end date
Actual end date 2018-01-29
Shortage status Resolved
Updated date 2018-01-30
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2018-01-30 French Compare
v10 2018-01-30 English Compare
v9 2018-01-19 French Compare
v8 2018-01-19 English Compare
v7 2018-01-03 English Compare
v6 2018-01-02 French Compare
v5 2018-01-02 English Compare
v4 2017-12-31 English Compare
v3 2017-12-20 French Compare
v2 2017-12-20 English Compare
v1 2017-12-20 English Compare

Showing 1 to 11 of 11